One of the world’s leading stem cell scientists has entered a partnership with the disgraced Korean researcher Hwang Woo-suk to pursue cloning research in China, Science reports.
Shoukhrat Mitalipov, of the Oregon Health & Science University in Portland, was the first to successfully derive stem cells from a cloned human embryo in 2013. A South Korean newspaper, Dong-A Ilbo, has revealed that he will be working with Hwang on both animal and human cloning.
Hwang came undone in 2006 after it was discovered that two papers he had published claiming that he had created human embryonic stem cells were bogus. He was convicted of fraud and bioethics violations but received a suspended sentence. For many Koreans, he is still a hero.
Mitalipov's "strength is in primate stem cells,” Hwang told the newspaper. “My specialty is in cell nuclear transplantation. So we've agreed that if we combine his strength with mine, we can create a breakthrough outcome in curing maternal line genetic disease, on which he is now focusing."
Providing US$93 million for their project will be the Boyalife Group of Wuxi, China. Hwang says the laboratories will be sited there because the bioethics laws in Korea are prohibitively strict.
This article is published by
and BioEdge under a Creative Commons licence. You may republish it or translate it free of charge with attribution for non-commercial purposes following these guidelines
. If you teach at a university we ask that your department make a donation. Commercial media must contact us
for permission and fees. Some articles on this site are published under different terms.